<VariationArchive VariationID="662037" VariationName="NM_207122.1(EXT2):c.861_1173+5287del" VariationType="Deletion" Accession="VCV000662037" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2019-08-14" MostRecentSubmission="2019-08-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="652126" VariationID="662037">
      <GeneList>
        <Gene Symbol="EXT2" FullName="exostosin glycosyltransferase 2" GeneID="2132" HGNC_ID="HGNC:3513" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="44095678" stop="44251962" display_start="44095678" display_stop="44251962" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="44117098" stop="44266979" display_start="44117098" display_stop="44266979" Strand="+" />
          </Location>
          <OMIM>608210</OMIM>
          <Haploinsufficiency last_evaluated="2020-06-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EXT2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-06-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EXT2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_207122.1(EXT2):c.861_1173+5287del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="44124906" stop="44135425" display_start="44124906" display_stop="44135425" variantLength="10520" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_494t2" sequenceAccession="LRG_494t2" change="c.861_1173+5287del">
            <Expression>LRG_494t2:c.861_1173+5287del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.44124906_44135425del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.44124906_44135425del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_207122.1(EXT2):c.861_1173+5287del AND Exostoses, multiple, type 2" Accession="RCV000819585" Version="2">
        <ClassifiedConditionList TraitSetID="622">
          <ClassifiedCondition DB="MedGen" ID="C1851413">Exostoses, multiple, type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-10-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-10-09" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-08-14" MostRecentSubmission="2019-08-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="622" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5054" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EXOSTOSES, MULTIPLE, TYPE II</ElementValue>
                <XRef Type="MIM" ID="133701" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608210.0002" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Exostoses, multiple, type 2</ElementValue>
                <XRef ID="MONDO:0007586" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EXT2</ElementValue>
                <XRef Type="MIM" ID="133701" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary multiple osteochondromas (HMO), previously called hereditary multiple exostoses (HME), is characterized by growths of multiple osteochondromas, benign cartilage-capped bone tumors that grow outward from the metaphyses of long bones. Osteochondromas can be associated with a reduction in skeletal growth, bony deformity, restricted joint motion, shortened stature, premature osteoarthrosis, and compression of peripheral nerves. The median age of diagnosis is three years; nearly all affected individuals are diagnosed by age 12 years. The risk for malignant degeneration to osteochondrosarcoma increases with age, although the lifetime risk for malignant degeneration is low (~2%-5%).</Attribute>
                <XRef ID="NBK1235" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2205" />
                <XRef ID="2205" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301413</ID>
                <ID Source="BookShelf">NBK1235</ID>
              </Citation>
              <XRef ID="321" DB="Orphanet" />
              <XRef ID="C1851413" DB="MedGen" />
              <XRef ID="MONDO:0007586" DB="MONDO" />
              <XRef Type="MIM" ID="133701" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1854552" SubmissionDate="2019-03-28" DateLastUpdated="2019-08-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="5188961|MedGen:C1851413" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000960253" DateUpdated="2019-08-14" DateCreated="2019-08-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-10-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is a deletion of the genomic region encompassing exons 6-7 and part of exon 5 (c.861_1173+5287del) of the EXT2 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. A similar deletion has been observed in an individual affected withÂ¬â€ hereditary multiple osteochondromatosisÂ¬â€ (PMID:Â¬â€ 22258776). Loss-of-function variants in EXT2 are known to be pathogenic (PMID: 19810120). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EXT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_207122.1:c.861_1173+5287del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Multiple exostoses type 2</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C1851413" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1854552" TraitType="Disease" MappingType="Name" MappingValue="Multiple exostoses type 2" MappingRef="Preferred">
        <MedGen CUI="C1851413" Name="Exostoses, multiple, type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

